-
1دورية أكاديمية
المؤلفون: Vogelmeier, CF, Chapman, KR, Miravitlles, M, Roche, N, Vestbo, J, Thach, C, Banerji, D, Fogel, R, Patalano, F, Olsson, P, Kostikas, K, Wedzicha, JA
المصدر: 1134 ; 1125
مصطلحات موضوعية: Science & Technology, Life Sciences & Biomedicine, Respiratory System, indacaterol/glycopyrronium, salmeterol/fluticasone, LABA/LAMA, LABA/ICS, OBSTRUCTIVE PULMONARY-DISEASE, SALMETEROL-FLUTICASONE, PARALLEL-GROUP, FULFILL TRIAL, LUNG-FUNCTION, DOUBLE-BLIND, QVA149, GLYCOPYRRONIUM, PREVENTION, 1102 Cardiovascular Medicine And Haematology
العلاقة: International Journal of Chronic Obstructive Pulmonary Disease; http://hdl.handle.net/10044/1/60364Test; https://dx.doi.org/10.2147/COPD.S160011Test
-
2
المؤلفون: Robert Fogel, Marc Miravitlles, Kenneth R. Chapman, Francesco Patalano, Konstantinos Kostikas, Nicolas Roche, Petter Olsson, Claus Vogelmeier, Jørgen Vestbo, Donald Banerji, Chau Thach, Jadwiga A. Wedzicha
المصدر: International Journal of COPD, Vol Volume 13, Pp 1125-1134 (2018)
Vogelmeier, C F, Chapman, K R, Miravitlles, M, Roche, N, Vestbo, J, Thach, C, Banerji, D, Fogel, R, Patalano, F, Olsson, P, Kostikas, K & Wedzicha, J A 2018, ' Exacerbation heterogeneity in COPD : Subgroup analyses from the FLAME study ', International Journal of COPD, vol. 13, pp. 1125-1134 . https://doi.org/10.2147/COPD.S160011Test
International Journal of Chronic Obstructive Pulmonary Diseaseمصطلحات موضوعية: Male, Time Factors, Exacerbation, Respiratory System, Vital Capacity, Kaplan-Meier Estimate, Quinolones, indacaterol/glycopyrronium, salmeterol/fluticasone, Rate ratio, Severity of Illness Index, DOUBLE-BLIND, Pulmonary Disease, Chronic Obstructive, 0302 clinical medicine, exacerbation, Adrenal Cortex Hormones, Risk Factors, Forced Expiratory Volume, Odds Ratio, 030212 general & internal medicine, Lung, Original Research, Fluticasone, COPD, Health Policy, General Medicine, Middle Aged, Fluticasone-Salmeterol Drug Combination, LABA/ICS, Bronchodilator Agents, 3. Good health, LUNG-FUNCTION, Hospitalization, Drug Combinations, Treatment Outcome, Indans, Disease Progression, Female, Salmeterol, IND/GLY, Life Sciences & Biomedicine, medicine.drug, Pulmonary and Respiratory Medicine, medicine.medical_specialty, PARALLEL-GROUP, animal structures, SFC, Subgroup analysis, Muscarinic Antagonists, International Journal of Chronic Obstructive Pulmonary Disease, OBSTRUCTIVE PULMONARY-DISEASE, SALMETEROL-FLUTICASONE, 1102 Cardiovascular Medicine And Haematology, Drug Administration Schedule, 03 medical and health sciences, FULFILL TRIAL, Double-Blind Method, Salmeterol/fluticasone, GLYCOPYRRONIUM, Internal medicine, Severity of illness, medicine, Humans, Adrenergic beta-2 Receptor Agonists, Indacaterol/glycopyrronium, Aged, Proportional Hazards Models, lcsh:RC705-779, Science & Technology, business.industry, Public Health, Environmental and Occupational Health, QVA149, lcsh:Diseases of the respiratory system, LABA/LAMA, medicine.disease, PREVENTION, Glycopyrrolate, 030228 respiratory system, Indacaterol, business
وصف الملف: text/html
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::efc722fc73e1f131714a6122b66807d7Test
https://www.dovepress.com/exacerbation-heterogeneity-in-copd-subgroup-analyses-from-the-flame-st-peer-reviewed-article-COPDTest